Bank of America
PVLA

Bank of America’s Palvella Therapeutics PVLA Stock Holding History

Bank of America’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73M Buy
37,972
+7,700
+25% +$803K ﹤0.01% 3516
2025
Q4 		$3.17M Buy
30,272
+25,583
+546% +$2.18M ﹤0.01% 3710
2025
Q3 		$294K Buy
4,689
+515
+12% +$23K ﹤0.01% 6099
2025
Q2 		$94.1K Sell
4,174
-3,435
-45% -$80.6K ﹤0.01% 6543
2025
Q1 		$213K Buy
7,609
+7,597
+63,308% +$146K ﹤0.01% 6140
2024
Q4 		$144 Sell
12
-1
-8% -$16 ﹤0.01% 7662
2024
Q3 		$215 Hold
13
– – ﹤0.01% 7551
2024
Q2 		$128 Sell
13
-64
-83% -$722 ﹤0.01% 7654
2024
Q1 		$1.13K Buy
77
+75
+3,750% +$1.04K ﹤0.01% 7187
2023
Q4 		$26 Hold
2
– – ﹤0.01% 7610
2023
Q3 		$43 Buy
+2
New +$43 ﹤0.01% 7521
2023
Q2 		– Sell
-278
Closed -$21.7K – 7998
2023
Q1 		$21.7K Sell
278
-45,543
-99% -$5.27M ﹤0.01% 6742
2022
Q4 		$3.81M Buy
45,821
+39,173
+589% +$3.15M ﹤0.01% 3651
2022
Q3 		$611K Sell
6,648
-418
-6% -$53.9K ﹤0.01% 5248
2022
Q2 		$1.06M Sell
7,066
-107
-1% -$19.5K ﹤0.01% 4859
2022
Q1 		$1.74M Buy
7,173
+1,834
+34% +$482K ﹤0.01% 4722
2021
Q4 		$1.61M Buy
5,339
+5,197
+3,660% +$1.66M ﹤0.01% 4773
2021
Q3 		$58K Sell
142
-61
-30% -$21.2K ﹤0.01% 6983
2021
Q2 		$62K Sell
203
-698
-77% -$153K ﹤0.01% 6735
2021
Q1 		$186K Buy
901
+349
+63% +$76.3K ﹤0.01% 6088
2020
Q4 		$111K Sell
552
-2,927
-84% -$609K ﹤0.01% 5937
2020
Q3 		$576K Buy
3,479
+3,196
+1,129% +$728K ﹤0.01% 4604
2020
Q2 		$71K Buy
283
+43
+18% +$10.1K ﹤0.01% 5827
2020
Q1 		$44K Sell
240
-201
-46% -$50.6K ﹤0.01% 5919
2019
Q4 		$128K Buy
441
+119
+37% +$33K ﹤0.01% 5880
2019
Q3 		$87K Sell
322
-226
-41% -$87.5K ﹤0.01% 6110
2019
Q2 		$206K Sell
548
-3,491
-86% -$1.04M ﹤0.01% 5618
2019
Q1 		$1.08M Buy
4,039
+572
+16% +$136K ﹤0.01% 4458
2018
Q4 		$739K Buy
3,467
+3,079
+794% +$955K ﹤0.01% 4641
2018
Q3 		$174K Buy
388
+93
+32% +$40.4K ﹤0.01% 5559
2018
Q2 		$119K Buy
295
+26
+10% +$12.4K ﹤0.01% 5710
2018
Q1 		$147K Buy
269
+63
+31% +$39K ﹤0.01% 5538
2017
Q4 		$124K Buy
206
+24
+13% +$11.2K ﹤0.01% 5650
2017
Q3 		$84K Sell
182
-24
-12% -$10.2K ﹤0.01% 5741
2017
Q2 		$83K Sell
206
-13
-6% -$3.8K ﹤0.01% 5673
2017
Q1 		$46K Hold
219
– – ﹤0.01% 5964
2016
Q4 		$25K Hold
219
– – ﹤0.01% 6251
2016
Q3 		$32K Buy
219
+31
+16% +$4.12K ﹤0.01% 5922
2016
Q2 		$24K Buy
188
+63
+50% +$9.65K ﹤0.01% 6166
2016
Q1 		$19K Hold
125
– – ﹤0.01% 6159
2015
Q4 		$23K Hold
125
– – ﹤0.01% 6373
2015
Q3 		$18K Buy
+125
New +$27.9K ﹤0.01% 6349

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America's PVLA Position: Q1 2026 in Review

Bank of America increased its Palvella Therapeutics (PVLA) stake by 25% in Q1 2026, buying an estimated $803K and bringing the position to 37,972 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3516.

Bank of America first reported a position in PVLA in Q3 2015 and has held it in 42 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Bank of America held 37,972 shares of Palvella Therapeutics worth $4.73M as of Q1 2026.
  • Bank of America bought 7,700 Palvella Therapeutics shares in Q1 2026, an estimated $803K.
  • Palvella Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3516 holding.
  • Bank of America first reported a position in Palvella Therapeutics in Q3 2015 and has held it in 42 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.